172 related articles for article (PubMed ID: 37770831)
1. Factors contributing to flares of ulcerative colitis in North India- a case-control study.
Rana VS; Mahajan G; Patil AN; Singh AK; Jearth V; Sekar A; Singh H; Saroch A; Dutta U; Sharma V
BMC Gastroenterol; 2023 Sep; 23(1):336. PubMed ID: 37770831
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of factors that trigger inflammatory bowel disease flares.
Feagins LA; Iqbal R; Spechler SJ
World J Gastroenterol; 2014 Apr; 20(15):4329-34. PubMed ID: 24764669
[TBL] [Abstract][Full Text] [Related]
3. High Perceived Stress is Associated With Increased Risk of Ulcerative Colitis Clinical Flares.
Sauk JS; Ryu HJ; Labus JS; Khandadash A; Ahdoot AI; Lagishetty V; Katzka W; Wang H; Naliboff B; Jacobs JP; Mayer EA
Clin Gastroenterol Hepatol; 2023 Mar; 21(3):741-749.e3. PubMed ID: 35952942
[TBL] [Abstract][Full Text] [Related]
4. Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.
Garcia PG; Chebli LA; da Rocha Ribeiro TC; Gaburri PD; de Lima Pace FH; Barbosa KVBD; Costa LA; de Almeida Cruz W; de Assis IC; Moraes BRM; Zanini A; Chebli JMF
Int J Colorectal Dis; 2018 Sep; 33(9):1285-1294. PubMed ID: 29926235
[TBL] [Abstract][Full Text] [Related]
5. Impact and risk factors of non-adherence to 5-aminosalicylates in quiescent ulcerative colitis evaluated by an electronic management system.
Ballester MP; Marti-Aguado D; Fullana M; Bosca-Watts MM; Tosca J; Romero E; Sanchez A; Navarro-Cortes P; Anton R; Mora F; Minguez M
Int J Colorectal Dis; 2019 Jun; 34(6):1053-1059. PubMed ID: 30963247
[TBL] [Abstract][Full Text] [Related]
6. Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares.
Higgins PD; Rubin DT; Kaulback K; Schoenfield PS; Kane SV
Aliment Pharmacol Ther; 2009 Feb; 29(3):247-57. PubMed ID: 18945258
[TBL] [Abstract][Full Text] [Related]
7. Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study.
Park J; Yoon H; Shin CM; Park YS; Kim N; Lee DH
PLoS One; 2022; 17(1):e0262571. PubMed ID: 35061808
[TBL] [Abstract][Full Text] [Related]
8. Self-reported frequency and severity of disease flares, disease perception, and flare treatments in patients with ulcerative colitis: results of a national internet-based survey.
Bolge SC; Waters H; Piech CT
Clin Ther; 2010 Feb; 32(2):238-45. PubMed ID: 20206781
[TBL] [Abstract][Full Text] [Related]
9. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.
Ananthakrishnan AN; Long MD; Martin CF; Sandler RS; Kappelman MD
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):965-71. PubMed ID: 23376797
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
Pearce CB; Duncan HD; Timmis L; Green JR
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):439-43. PubMed ID: 10783998
[TBL] [Abstract][Full Text] [Related]
11. eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis.
Pedersen N; Thielsen P; Martinsen L; Bennedsen M; Haaber A; Langholz E; Végh Z; Duricova D; Jess T; Bell S; Burisch J; Munkholm P
Inflamm Bowel Dis; 2014 Dec; 20(12):2276-85. PubMed ID: 25248002
[TBL] [Abstract][Full Text] [Related]
12. Long-term oral mesalazine adherence and the risk of disease flare in ulcerative colitis: nationwide 10-year retrospective cohort from the veterans affairs healthcare system.
Khan N; Abbas AM; Bazzano LA; Koleva YN; Krousel-Wood M
Aliment Pharmacol Ther; 2012 Oct; 36(8):755-64. PubMed ID: 22882428
[TBL] [Abstract][Full Text] [Related]
13. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
14. Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience.
Erdoğan Ç; Yeşil B; Bacaksız F; Arı D; Gökbulut V; Yüksel M; Özderin Özin Y; Kayaçetin E
Turk J Gastroenterol; 2022 Oct; 33(10):831-837. PubMed ID: 35946879
[TBL] [Abstract][Full Text] [Related]
15. Long-term mesalamine maintenance in ulcerative colitis: which is more important? Adherence or daily dose.
Khan N; Abbas AM; Koleva YN; Bazzano LA
Inflamm Bowel Dis; 2013 May; 19(6):1123-9. PubMed ID: 23514878
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Combination Antibiotic Therapy for Refractory Pediatric Inflammatory Bowel Disease.
Breton J; Kastl A; Hoffmann N; Rogers R; Grossman AB; Mamula P; Kelsen JR; Baldassano RN; Albenberg L
Inflamm Bowel Dis; 2019 Aug; 25(9):1586-1593. PubMed ID: 30715364
[TBL] [Abstract][Full Text] [Related]
17. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic use and the risk of flare of inflammatory bowel disease.
Aberra FN; Brensinger CM; Bilker WB; Lichtenstein GR; Lewis JD
Clin Gastroenterol Hepatol; 2005 May; 3(5):459-65. PubMed ID: 15880315
[TBL] [Abstract][Full Text] [Related]
19. The Frequency of Clinic Visits Was Not Associated with Medication Adherence or Outcome in Children with Inflammatory Bowel Diseases.
Kluthe C; Tsui J; Spady D; Carroll M; Wine E; Huynh HQ
Can J Gastroenterol Hepatol; 2018; 2018():4687041. PubMed ID: 29682493
[TBL] [Abstract][Full Text] [Related]
20. High Dietary Intake of Specific Fatty Acids Increases Risk of Flares in Patients With Ulcerative Colitis in Remission During Treatment With Aminosalicylates.
Barnes EL; Nestor M; Onyewadume L; de Silva PS; Korzenik JR;
Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1390-1396.e1. PubMed ID: 28110099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
